Biomason

Durham, NC · Founded 2012 · Privately Held (backing)

Developer of a building materials technology designed to harness biology to produce high-quality concrete, replace Portland cement, and cut carbon emissions. Biomason is based in Durham, NC and was founded in 2012. It was valued at $187 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $133 million across 6 recorded rounds; the latest was a $36.7 million early-stage round in Dec 2024.

PMV mark · valuation
$186.7M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$132.9M
Last round
Early Stage VC
Dec 2024

Biomason key facts

as of Oct 2026
  • Developer of a building materials technology designed to harness biology to produce high-quality concrete, replace Portland cement, and cut carbon emissions.
  • Biomason is valued at approximately $186.7M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $132.9M across 6 recorded rounds; the latest was Early Stage VC ($36.7M) in Dec 2024.
  • Notable investors include US National Science Foundation, United States Department of War, Novo Holdings, Celesta Capital, 2150 — 12 tracked in total.
  • Biomason has filed 7 Form Ds with the SEC since 2013, most recently Jan 2025 ($36.7M sold to 6 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$186.7M

Valued at $186.7M at its later-stage round, Dec 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Biomason with a free account
  • ·The complete investor list: 12 names
  • ·Watch Biomason: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Biomason funding rounds

6 rounds
Dec 2024Early Stage VC$36.7MSEC filing▮
Feb 2022Later Stage VC$65.0MSEC filing▮
Nov 2019Seed Round$5.0MSEC filing▮
Apr 2017Debt$3.4MSEC filing▮
Dec 2015Seed Round$1.5MSEC filing▮

Biomason valuation

Biomason was valued at $187 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Biomason raised?

Biomason has raised $133 million across 6 recorded rounds since 2013. The largest was a $65 million later-stage round in Feb 2022; the most recent was a $36.7 million early-stage round in Dec 2024.

Biomason has filed 7 Form Ds with the SEC since 2013, most recently in Jan 2025 ($36.7 million sold to 6 investors).

Biomason investors

12 investors are on record for Biomason, including US National Science Foundation, United States Department of War, Novo Holdings and Celesta Capital. The early-stage round in Dec 2024 drew 6 investors.

About Biomason

Developer of a building materials technology designed to harness biology to produce high-quality concrete, replace Portland cement, and cut carbon emissions. The company's technology combines natural microorganisms and chemical processes to develop masonry materials at room temperature, which helps replace traditional clay and concrete and the energy consumption associated with standard manufacturing them, enabling builders to acquire alternative building materials that are produced carbon-free.

Sector
Materials and Resources
HQ
Durham, NC, United States
Founded
2012
Employees
59
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.